- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana publishes November newsletter
Dignitana AB today publishes the November 2020 newsletter highlighting the recent announcement from the American Medical Association of a CPT® code that will be issued in 2021. To read the newsletter click here.
The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market.
To subscribe to receive future Dignitana news directly to your email, click here.
For More Information Contact
Melissa Bourestom, VP Corporate Communications firstname.lastname@example.org +1 469-518-5031
About DignitanaDignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB, +46 8 121 576 90, email@example.com and www.redeye.se. Learn more at www.dignitana.se and www.dignicap.com.